Preclinical Organotypic Models for the Assessment of Novel Cancer Therapeutics and Treatment

Carol Ward*, James Meehan, Mark Gray, Ian H. Kunkler, Simon P. Langdon, Alan Murray, David Argyle

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Fingerprint

Dive into the research topics of 'Preclinical Organotypic Models for the Assessment of Novel Cancer Therapeutics and Treatment'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology